Ambu AS (WBO:AMBU) Cyclically Adjusted PS Ratio: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:AMBU Ambu AS WBO:AMBU
63 GF Score
Price €10.26
GF Value €17.53
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ambu AS  (WBO:AMBU) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ambu AS Cyclically Adjusted PS Ratio Related Terms


Ambu AS Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Ambu AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Cyclically Adjusted PS Ratio Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.32 5.48 5.50 8.83 5.60

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.49 6.16 5.60 5.22 3.97

WBO:AMBU vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Ambu AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ambu AS's Cyclically Adjusted PS Ratio falls into.


WBO:AMBU
63GF Score
Ambu AS WBO:AMBU
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ambu AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Ambu AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.8/330.2130*330.2130
=0.800

Current CPI (Mar. 2026) = 330.2130.

Ambu AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.284 241.018 0.389
201609 0.321 241.428 0.439
201612 0.293 241.432 0.401
201703 0.343 243.801 0.465
201706 0.335 244.955 0.452
201709 0.349 246.819 0.467
201712 0.292 246.524 0.391
201803 0.346 249.554 0.458
201806 0.363 251.989 0.476
201809 0.403 252.439 0.527
201812 0.349 251.233 0.459
201903 0.421 254.202 0.547
201906 0.417 256.143 0.538
201909 0.330 256.759 0.424
201912 0.412 256.974 0.529
202003 0.534 258.115 0.683
202006 0.511 257.797 0.655
202009 0.468 260.280 0.594
202012 0.539 260.474 0.683
202103 0.538 264.877 0.671
202106 0.506 271.696 0.615
202109 0.544 274.310 0.655
202112 0.555 278.802 0.657
202203 0.595 287.504 0.683
202206 0.595 296.311 0.663
202209 0.607 296.808 0.675
202212 0.622 296.797 0.692
202303 0.639 301.836 0.699
202306 0.598 305.109 0.647
202309 0.633 307.789 0.679
202312 0.640 306.746 0.689
202403 0.688 312.332 0.727
202406 0.691 314.175 0.726
202409 0.703 315.301 0.736
202412 0.752 315.605 0.787
202503 0.787 319.799 0.813
202506 0.755 322.561 0.773
202509 0.734 324.800 0.746
202512 0.778 324.054 0.793
202603 0.800 330.213 0.800

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ambu AS (WBO:AMBU) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of €10.26 is trading 41.5% below its estimated GF Value™ of €17.53. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for WBO:AMBU:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €17.53 vs. price of €10.26 (41.5% below fair value)
  • GF Score™: 63/100

No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score

Get the complete analysis for WBO:AMBU

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.26
Price
€17.53
GF Value